Table 1.
Study participant characteristics and association with M. genitalium (MG) infection.
| Study Cohort Characteristics | ||||
|---|---|---|---|---|
| Characteristic | Overall (N=232) | MG Negative (N=204) | MG Positive(N=28) | p-Value |
| Median age (Range) | 25.0 (18.0 – 56.0) | 26.0 (18.0 – 56.0) | 21.5 (18.0 – 52.0) | 0.01 |
| Gender | 0.69 | |||
| Male | 116 | 103 (88.8%) | 13 (11.2%) | |
| Female | 116 | 101 (87.1%) | 15 (12.9%) | |
| Male Participant Characteristics | ||||
| Characteristic | Overall (N=116) | MG Negative (N=103) | MG Positive (N=13) | p-Value |
| Median age (Range) | 26.0 (19.0, 56.0) | 26.0 (19.0, 56.0) | 25.0 (21.0, 52.0) | 0.60 |
| Trichomoniasis | 11 (9.5%) | 11 (10.7%) | 0 (0%) | 0.61 |
| Chlamydia | 23 (19.8%) | 21 (20.4%) | 2 (15.4%) | 1.00 |
| Gonorrhea | 14 (12.1%) | 10 (9.7%) | 4 (30.8%) | 0.05 |
| Urethral Gram Stain PMNs | 0.14 | |||
| <5/hpf | 53 (45.7%) | 50 (48.5%) | 3 (23.1%) | |
| ≥5/hpf | 63 (54.3%) | 53 (51.5%) | 10 (76.9%) | |
| Circumcised | 100 (86.2%) | 89 (85.4%) | 12 (92.3%) | 0.69 |
| Urethral discharge symptom | 26 (22.6%) | 20 (19.6%) | 6 (46.2%) | 0.03 |
| Urethral discharge finding | 28 (24.1%) | 22 (21.4%) | 6 (46.2%) | 0.05 |
| Female Partner Characteristics | ||||
| Characteristic | Overall (N=116) | MG Negative (N=101) | MG Positive(N=15) | p-Value |
| Median age (Range) | 23.5 (18.0, 46.0) | 25.0 (18.0, 46.0) | 20.0 (18.0, 33.0) | 0.001 |
| Hormonal contraception | 21 (18.1%) | 17 (16.8%) | 4 (26.7%) | 0.47 |
| Bacterial vaginosis | 55 (47.4%) | 51 (50.5%) | 4 (26.7%) | 0.10 |
| Trichomoniasis | 23 (19.8%) | 22 (21.8%) | 1 (6.7%) | 0.30 |
| Chlamydia | 24 (20.7%) | 22 (21.8%) | 2 (13.3%) | 0.73 |
| Gonorrhea | 15 (12.9%) | 14 (13.9%) | 1 (6.7%) | 0.69 |
| Cervical discharge | 16 (14.2%) | 14 (14.3%) | 2 (13.3%) | 1.00 |
| Vaginal discharge symptom | 35 (30.2%) | 28 (27.7%) | 7 (46.7%) | 0.14 |
| Vaginal discharge finding | 93 (80.2%) | 82 (81.2%) | 11 (73.3%) | 0.49 |